vs
Side-by-side financial comparison of Ares Commercial Real Estate Corp (ACRE) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.
Ares Commercial Real Estate Corp is the larger business by last-quarter revenue ($13.2M vs $7.8M, roughly 1.7× CRYO CELL INTERNATIONAL INC). Ares Commercial Real Estate Corp runs the higher net margin — -29.2% vs -48.7%, a 19.4% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -24.5%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -15.9%).
Ares Commercial Real Estate Corp is a specialty finance company focused on the commercial real estate sector. It offers a full suite of customized financing solutions including senior mortgage loans, subordinated debt and preferred equity, primarily serving middle-market commercial property owners and operators across the United States.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
ACRE vs CCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $7.8M |
| Net Profit | $-3.9M | $-3.8M |
| Gross Margin | — | 77.9% |
| Operating Margin | -29.2% | -50.6% |
| Net Margin | -29.2% | -48.7% |
| Revenue YoY | -24.5% | -2.3% |
| Net Profit YoY | 63.8% | -105.1% |
| EPS (diluted) | — | $-0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $7.8M | ||
| Q3 25 | $14.1M | $7.8M | ||
| Q2 25 | $12.6M | $7.9M | ||
| Q1 25 | $14.9M | $8.0M | ||
| Q4 24 | $17.5M | $8.0M | ||
| Q3 24 | $16.7M | $8.1M | ||
| Q2 24 | $16.8M | $8.0M | ||
| Q1 24 | $18.7M | $7.9M |
| Q4 25 | $-3.9M | $-3.8M | ||
| Q3 25 | $4.7M | $749.4K | ||
| Q2 25 | $-11.0M | $355.8K | ||
| Q1 25 | $9.3M | $282.9K | ||
| Q4 24 | $-10.7M | $-1.9M | ||
| Q3 24 | $-5.9M | $1.1M | ||
| Q2 24 | $-6.1M | $655.8K | ||
| Q1 24 | $-12.3M | $556.2K |
| Q4 25 | — | 77.9% | ||
| Q3 25 | — | 77.0% | ||
| Q2 25 | — | 76.6% | ||
| Q1 25 | — | 75.1% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 73.6% | ||
| Q2 24 | — | 74.8% | ||
| Q1 24 | — | 73.7% |
| Q4 25 | -29.2% | -50.6% | ||
| Q3 25 | 33.0% | 24.3% | ||
| Q2 25 | -87.8% | 18.8% | ||
| Q1 25 | 64.4% | 13.3% | ||
| Q4 24 | -61.0% | -1.5% | ||
| Q3 24 | -35.3% | 17.2% | ||
| Q2 24 | -36.5% | 17.3% | ||
| Q1 24 | -65.9% | 10.5% |
| Q4 25 | -29.2% | -48.7% | ||
| Q3 25 | 33.0% | 9.6% | ||
| Q2 25 | -87.8% | 4.5% | ||
| Q1 25 | 62.5% | 3.5% | ||
| Q4 24 | -60.9% | -23.2% | ||
| Q3 24 | -35.3% | 13.0% | ||
| Q2 24 | -36.5% | 8.2% | ||
| Q1 24 | -65.9% | 7.1% |
| Q4 25 | — | $-0.46 | ||
| Q3 25 | — | $0.09 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $0.13 | ||
| Q2 24 | — | $0.08 | ||
| Q1 24 | — | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.3M | $3.3M |
| Total DebtLower is stronger | $948.2M | $8.4M |
| Stockholders' EquityBook value | $509.6M | $-18.6M |
| Total Assets | $1.6B | $61.7M |
| Debt / EquityLower = less leverage | 1.86× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.3M | $3.3M | ||
| Q3 25 | $84.9M | $3.2M | ||
| Q2 25 | $90.0M | $4.4M | ||
| Q1 25 | $125.5M | $3.5M | ||
| Q4 24 | $63.8M | $3.5M | ||
| Q3 24 | $68.9M | $2.1M | ||
| Q2 24 | $70.6M | $1.5M | ||
| Q1 24 | $99.5M | $979.6K |
| Q4 25 | $948.2M | $8.4M | ||
| Q3 25 | — | $8.4M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | $718.5M | $8.5M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | $509.6M | $-18.6M | ||
| Q3 25 | $521.0M | $-14.8M | ||
| Q2 25 | $523.7M | $-15.6M | ||
| Q1 25 | $542.1M | $-14.7M | ||
| Q4 24 | $540.1M | $-13.2M | ||
| Q3 24 | $563.8M | $-9.6M | ||
| Q2 24 | $582.3M | $-10.7M | ||
| Q1 24 | $601.1M | $-10.3M |
| Q4 25 | $1.6B | $61.7M | ||
| Q3 25 | $1.4B | $63.2M | ||
| Q2 25 | $1.4B | $64.4M | ||
| Q1 25 | $1.5B | $64.4M | ||
| Q4 24 | $1.8B | $64.7M | ||
| Q3 24 | $1.9B | $62.9M | ||
| Q2 24 | $2.1B | $62.6M | ||
| Q1 24 | $2.1B | $61.7M |
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $21.4M | $1.3M |
| Free Cash FlowOCF − Capex | — | $1.2M |
| FCF MarginFCF / Revenue | — | 15.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.4M | $1.3M | ||
| Q3 25 | $3.8M | $2.5M | ||
| Q2 25 | $4.9M | $707.0K | ||
| Q1 25 | $8.0M | $954.1K | ||
| Q4 24 | $35.5M | $2.2M | ||
| Q3 24 | $8.4M | $2.4M | ||
| Q2 24 | $8.7M | $1.8M | ||
| Q1 24 | $11.4M | $-356.9K |
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $644.6K | ||
| Q1 25 | — | $892.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $21.5K | ||
| Q1 24 | — | $-814.6K |
| Q4 25 | — | 15.5% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 26.8% | ||
| Q3 24 | — | 27.9% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | 5.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | 3.38× | ||
| Q2 25 | — | 1.99× | ||
| Q1 25 | 0.86× | 3.37× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.32× | ||
| Q2 24 | — | 2.70× | ||
| Q1 24 | — | -0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
